Irene Badal was diagnosed with essential thrombocythemia (ET) in 2000 at the age of 52. After two fingers on her right hand started turning blue, she was concerned that she had a blood clot and saw a cardiologist. Through a series of blood tests, it was discovered that her platelets were very high, and she was referred to a hematologist. Irene’s ET was managed well for many years via standard treatments. Finally, in 2008, her doctor referred her to Dr. Verstovsek at MD Anderson and suggested that there may be a research trial that would work well. After meeting with Dr. Verstovsek, Irene started a clinical trial and she’s been on the same trial since 2010. Today, she is doing very well, gets blood work every 3 months and sees Dr. Verstovsek twice a year. In her spare time, Irene enjoys taking walks, reading, and spending time with her two children and three grandchildren who live close by.